Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin. Breast Cancer Res Treat. 2016 Feb; 156(1):33-43.
View in:
PubMed
subject areas
Aspirin
Breast Neoplasms
Cell Proliferation
Class I Phosphatidylinositol 3-Kinases
Cytostatic Agents
Female
Glycogen Synthase Kinase 3 beta
Humans
MCF-7 Cells
Mutation
Phosphatidylinositol 3-Kinases
Phosphorylation
Proto-Oncogene Proteins p21(ras)
authors with profiles
Abde Abukhdeir
Melody Cobleigh